Predicting safe patient discharge post percutaneous revascularisatio
Not Applicable
Completed
- Conditions
- Ischaemic heart disease patients presenting for PCICirculatory SystemIschaemic heart disease
- Registration Number
- ISRCTN52922229
- Lead Sponsor
- Randox Laboratories (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 275
Inclusion Criteria
1. Aged over 18 at enrolment
2. Undergoing Percutaneous Coronary Intervention (PCI) for chronic stable angina or as part of staged procedure following acute coronary syndrome (ACS)/myocardial infarction (MI) (index event >14 days previously)
Exclusion Criteria
1. Terminal malignancy
2. Inability to give informed consent due to impaired mental capacity
3. ACS/chest pain at admission/MI within last 14 days
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method